{"title":"New approaches to treat cancer - what they can and cannot do.","authors":"Nalân Utku","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Delivering drugs directly to tumors and overcoming drug resistance are two hurdles that face cancer researchers. Here's a look at where cancer treatment stands.</p>","PeriodicalId":89534,"journal":{"name":"Biotechnology healthcare","volume":"8 4","pages":"25-7"},"PeriodicalIF":0.0,"publicationDate":"2011-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3278133/pdf/bh0804025.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"30554932","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Needed: a new business model.","authors":"F Randy Vogenberg","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":89534,"journal":{"name":"Biotechnology healthcare","volume":"8 3","pages":"9"},"PeriodicalIF":0.0,"publicationDate":"2011-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3278119/pdf/bh0803009.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"30553397","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Employers Struggle To Cope With the Rising Use of Biologics: Tradeoffs in cost sharing or higher deductibles could derail treatment and decrease the value of healthcare spending.","authors":"Lola Butcher","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Employers have tried everything from uptiering to tighter utilization management in trying to mitigate the high cost of biologics. They now hope that biosimilars may offer some relief. But there's another option - one they should take a hard look at.</p>","PeriodicalId":89534,"journal":{"name":"Biotechnology healthcare","volume":"8 4","pages":"21-4"},"PeriodicalIF":0.0,"publicationDate":"2011-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3278132/pdf/bh0804021.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"30554931","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Clinical trials, research, and FDA findings.","authors":"Alan Caspi","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":89534,"journal":{"name":"Biotechnology healthcare","volume":"8 2","pages":"5-6"},"PeriodicalIF":0.0,"publicationDate":"2011-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3138385/pdf/bth08_2p005.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"30555149","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Resurrection of preterm labor drug evokes questions of fairness.","authors":"Tom Morrow","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Big prices for small-market biopharmaceuticals is nothing new. But when the market is centered around a public health concern, pricing can trigger contentious issues.</p>","PeriodicalId":89534,"journal":{"name":"Biotechnology healthcare","volume":"8 2","pages":"27-9"},"PeriodicalIF":0.0,"publicationDate":"2011-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3138388/pdf/bth08_2p027.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"30555155","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Gene Patent Reform: Still in Doubt: The patent-eligibility doctrine remains in limbo as the battle over gene patents cuts a tortuous path through the court system.","authors":"Joanna T Brougher","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":89534,"journal":{"name":"Biotechnology healthcare","volume":"8 4","pages":"28-9"},"PeriodicalIF":0.0,"publicationDate":"2011-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3278130/pdf/bh0804028.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"30554933","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Clinical trials, research, and FDA findings.","authors":"Alan Caspi","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":89534,"journal":{"name":"Biotechnology healthcare","volume":"8 3","pages":"10-1"},"PeriodicalIF":0.0,"publicationDate":"2011-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3278116/pdf/bh0803010.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"30553395","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Managing Viral Hepatitis C: HCV: New Opportunities, High CostTwo new biologics establish a higher standard of care. Managing these agents, however, will be highly complex.","authors":"Jennifer Cawood","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Two new biologics for HCV present treatment and cost-management challenges.</p>","PeriodicalId":89534,"journal":{"name":"Biotechnology healthcare","volume":"8 3","pages":"26-8"},"PeriodicalIF":0.0,"publicationDate":"2011-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3278124/pdf/bh0803026.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"30553401","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Therapeutic vaccine for brain cancer succeeds using a unique approach.","authors":"Bob Carlson","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":89534,"journal":{"name":"Biotechnology healthcare","volume":"8 3","pages":"31-2"},"PeriodicalIF":0.0,"publicationDate":"2011-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3278117/pdf/bh0803031.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"30553404","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}